Different whole-brain functional connectivity correlates of reactive-proactive aggression and callous-unemotional traits in children and adolescents with disruptive behaviors.

"appendix a supplementary data the following are the supplementary data to this article: supplementary data 1 data availability data will be made available on request. data availability data will be made available on request. acknowledgements this project has received funding from the european union's seventh framework programme for research technological development and demonstration under grant agreement 602805"

"Declaration of competing interest TB has served in an advisory or consultancy role for Actelion, Hexal Pharma, Lilly, Lundbeck, Medice, Neurim Pharmaceuticals, Novartis, and Shire; he received conference support or speaker’s fees from Lilly, Medice, Novartis, and Shire. He has also been involved in clinical trials conducted by Shire and Viforpharma and has received royalties from Hogrefe, Kohlhammer, CIP Medien, and Oxford University Press. CA has been a consultant to or has received honoraria or grants from Acadia, Ambrosseti, Gedeon Richter, Janssen Cilag, Lundbeck, Merck, Otsuka, Roche, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion, and Takeda. DB served as an unpaid scientific advisor for an EU-funded neurofeedback trial unrelated to the present work. BF receives funding from a personal Vici grant from the Dutch Organisation for Scientific Research (Grant 016 130 669) and the Dutch National Science Agenda for the NWANeurolabNL project (Grant 400 17 602). She received educational speaking fees from Shire and Medicine. S.W. has received in the last 5 years royalties from Thieme, Hogrefe, Kohlhammer, Springer, and Beltz. In 2023, she received speakers honorary from Takeda and Medice. Her work was supported in the last years by the Swiss National Science Foundation (SNF), diff. EU FP7s, HSM Hochspezialisierte Medizin of the Kanton Zurich, Switzerland, Bfarm Germany, ZInEP, Hartmann Müller Stiftung, Olga Mayenfisch, Gertrud Thalmann, Vontobel, Unicentia, Erika Schwarz, Heuberg Fonds, National Government of Health (BAG), Gesundheitsförderung Schweiz, and Horizon Europe. Outside professional activities and interests are declared on the web page of the University of Zurich (https://www.uzh.ch/prof/ssl-dir/interessenbindungen/client/web/)."

"This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement 602805 (Aggressotype) and no 603016 (MATRICS). This manuscript reflects only the authors’ views, and the European Union is not liable for any use that may be made of the information contained herein."